News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,660 Results
Type
Article (39803)
Company Profile (307)
Press Release (649550)
Section
Business (206527)
Career Advice (2043)
Deals (35801)
Drug Delivery (82)
Drug Development (82027)
Employer Resources (171)
FDA (16113)
Job Trends (15102)
News (348849)
Policy (32747)
Tag
Academia (2549)
Africa (736)
Alliances (49796)
Alzheimer's disease (1184)
Approvals (16044)
Arizona (178)
Artificial intelligence (85)
Asia (38143)
Australia (6147)
Bankruptcy (354)
Best Places to Work (11460)
Biotechnology (219)
Breast cancer (72)
C2C Services and Suppliers (79051)
California (2116)
Canada (1003)
Cancer (601)
Career advice (1700)
Cell therapy (150)
China (168)
Clinical research (64473)
Collaboration (193)
Colorado (88)
Compensation (103)
Connecticut (91)
COVID-19 (2522)
Cystic fibrosis (79)
Data (476)
Diabetes (96)
Diagnostics (6022)
Drug pricing (74)
Earnings (84706)
Employer resources (146)
Europe (82042)
Events (110418)
Executive appointments (187)
FDA (16412)
Florida (304)
Funding (181)
Gene therapy (102)
Georgia (68)
GLP-1 (548)
Government (4342)
Healthcare (18697)
Hotbed/Location (485477)
Illinois (274)
Indiana (156)
Infectious disease (2559)
Inflammatory bowel disease (95)
Interviews (323)
IPO (16447)
Job creations (3829)
Job search strategy (1460)
Kansas (94)
Layoffs (413)
Legal (7884)
Lung cancer (120)
Manufacturing (111)
Maryland (441)
Massachusetts (1742)
Medical device (13086)
Medtech (13091)
Mergers & acquisitions (19260)
Metabolic disorders (289)
Michigan (131)
Minnesota (225)
Neuroscience (1369)
New Jersey (653)
New York (660)
NextGen Class of 2024 (6541)
Non-profit (4477)
North Carolina (648)
Northern California (919)
Obesity (172)
Ohio (115)
Opinion (189)
Patents (79)
Pennsylvania (633)
People (56773)
Pharmaceutical (76)
Phase I (20012)
Phase II (28442)
Phase III (21150)
Pipeline (137)
Postmarket research (2559)
Preclinical (8482)
Radiopharmaceuticals (240)
Rare diseases (152)
Real estate (6008)
Regulatory (21536)
Research institute (2329)
Resumes & cover letters (352)
South America (1116)
Southern California (851)
Startups (3643)
Texas (281)
United States (9512)
Vaccines (503)
Washington State (267)
Weight loss (143)
Date
Today (143)
Last 7 days (710)
Last 30 days (2876)
Last 365 days (37397)
2024 (27742)
2023 (40659)
2022 (51785)
2021 (56343)
2020 (54541)
2019 (46985)
2018 (35392)
2017 (32638)
2016 (32065)
2015 (38116)
2014 (32009)
2013 (26902)
2012 (29018)
2011 (29672)
2010 (27710)
689,660 Results for "sunshine biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Sunshine Biopharma, Inc. today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission.
May 21, 2024
·
3 min read
Deals
Sunshine Biopharma Announces Reverse Stock Split
Sunshine Biopharma, Inc. announced today a one for one hundred reverse split of its common stock, effective at market open on April 17, 2024.
April 12, 2024
·
2 min read
Press Releases
Sunshine Biopharma Launches Two New Generic Prescription Drugs
September 27, 2024
·
2 min read
Pharm Country
Sunshine Biopharma’s Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Sunshine Biopharma Inc. is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora Pharma, has received approval for its first Biosimilar product.
April 19, 2024
·
3 min read
Business
Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
Sunshine Biopharma Inc. today announced that it has filed its 2023 financial results on Form 10-K on Thursday March 28, 2024.
April 1, 2024
·
3 min read
Pharm Country
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
Sunshine Biopharma, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately $10.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
February 15, 2024
·
4 min read
Deals
Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
Sunshine Biopharma, Inc. today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $10.0 million, before deducting underwriting fees and other estimated offering expenses payable by the Company.
February 13, 2024
·
5 min read
News
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
September 4, 2024
·
5 min read
Business
Sunshine Biopharma Moves Principal Office to New York City
Sunshine Biopharma, Inc., a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals announced that it has moved its headquarters to New York City.
December 4, 2023
·
2 min read
Press Releases
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada
August 26, 2024
·
3 min read
1 of 68,966
Next
